Curasan AG operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Curasan AG with three other
pharmaceutical manufacturers in Europe:
Medincell SA
of France
(2018
sales of 6.44 million Euro [US$7.13 million]
),
Transgene
of France
(7.08 million Euro [US$7.84 million]
of which 81%
was Research & Development Tax Credit), and
CO.DON AG
(5.65 million Euro [US$6.26 million]
of which 100%
was Product sales).
Sales Analysis.
Curasan AG reported sales of 5.84 million Euro (US$6.47 million)
for the
year ending
December of 2018.
This
represents
a
decrease of 14.0%
versus 2017, when the company's sales were 6.80 million Euro.
The sales level in 2018 was fairly close to the level five years ago: in 2013, Curasan AG had sales
of 5.83 million Euro.